PHENYLDIFLUOROMETHYL-SUBSTITUTED PROLINAMIDE COMPOUND

[Problem]To provide a compound useful as a cathepsin S inhibitor.[Means for Solution]The present inventors have examined a compound that has a cathepsin S inhibitory effect and is usable as an active ingredient of a pharmaceutical composition for preventing and/or treating autoimmune disease includi...

Full description

Saved in:
Bibliographic Details
Main Authors TSUCHIYA Kazuyuki, IMADA Sunao, YAMAMOTO Eriko, MATSUMOTO Shunichiro, NAKAJIMA Yutaka, HARAYAMA Yu
Format Patent
LanguageEnglish
Slovenian
Published 30.11.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract [Problem]To provide a compound useful as a cathepsin S inhibitor.[Means for Solution]The present inventors have examined a compound that has a cathepsin S inhibitory effect and is usable as an active ingredient of a pharmaceutical composition for preventing and/or treating autoimmune disease including systemic lupus erythematosus (SLE) and lupus nephritis, allergies, or graft rejection of an organ, bone marrow or tissue, and have found that a phenyldifluoromethyl-substituted prolinamide compound of the present invention has the cathepsin S inhibitory effect, thereby completing the present invention. The phenyldifluoromethyl-substituted prolinamide compound of the present invention has the cathepsin S inhibitory effect and is useful as an agent for preventing and/or treating autoimmune disease including SLE and nephritis, allergies, or graft rejection of an organ, bone marrow or tissue.
AbstractList [Problem]To provide a compound useful as a cathepsin S inhibitor.[Means for Solution]The present inventors have examined a compound that has a cathepsin S inhibitory effect and is usable as an active ingredient of a pharmaceutical composition for preventing and/or treating autoimmune disease including systemic lupus erythematosus (SLE) and lupus nephritis, allergies, or graft rejection of an organ, bone marrow or tissue, and have found that a phenyldifluoromethyl-substituted prolinamide compound of the present invention has the cathepsin S inhibitory effect, thereby completing the present invention. The phenyldifluoromethyl-substituted prolinamide compound of the present invention has the cathepsin S inhibitory effect and is useful as an agent for preventing and/or treating autoimmune disease including SLE and nephritis, allergies, or graft rejection of an organ, bone marrow or tissue.
Author IMADA Sunao
NAKAJIMA Yutaka
TSUCHIYA Kazuyuki
HARAYAMA Yu
YAMAMOTO Eriko
MATSUMOTO Shunichiro
Author_xml – fullname: TSUCHIYA Kazuyuki
– fullname: IMADA Sunao
– fullname: YAMAMOTO Eriko
– fullname: MATSUMOTO Shunichiro
– fullname: NAKAJIMA Yutaka
– fullname: HARAYAMA Yu
BookMark eNrjYmDJy89L5WQwDfBw9Yv0cfF08wn1D_L3dQ3xiPTRDQ51Cg7xDAkNcXVRCAjy9_H0c_T1dHFVcPb3DfAP9XPhYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxwZ7GpuamRhYmISGGxsSoAQBmiSrR
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Spojina fenildifluorometil substituiranega prolinamida
ExternalDocumentID SI3575284TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_SI3575284TT13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:19:26 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Slovenian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SI3575284TT13
Notes Application Number: SI20180030429T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211130&DB=EPODOC&CC=SI&NR=3575284T1
ParticipantIDs epo_espacenet_SI3575284TT1
PublicationCentury 2000
PublicationDate 20211130
PublicationDateYYYYMMDD 2021-11-30
PublicationDate_xml – month: 11
  year: 2021
  text: 20211130
  day: 30
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies Astellas Pharma Inc
RelatedCompanies_xml – name: Astellas Pharma Inc
Score 3.3691306
Snippet [Problem]To provide a compound useful as a cathepsin S inhibitor.[Means for Solution]The present inventors have examined a compound that has a cathepsin S...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PHENYLDIFLUOROMETHYL-SUBSTITUTED PROLINAMIDE COMPOUND
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211130&DB=EPODOC&locale=&CC=SI&NR=3575284T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT4MwFH9ZplFvOjU6P4KJ4UZUGGMciBEKAQOUjGK207LCSJYYtgjGf98HgnrRW9Mmr-1Lfu-jfR8At2OuT_R8pEmpxjVptMwViWuZKmmpgi4RWui8iSYMwrGbjJ5n6qwH6y4XpqkT-tEUR0REpYj3qpHX259HLNLEVpZ3fI1Tm0eHGURsvWO5bpx-LxLTsCNKqCValhF7Yjg1FDRLUBIzdJR20IrWajDYL2adlLL9rVGcQ9iNkFhRHUGvfB3AvtU1XhvAXtD-d-OwhV55DGrk2uHcJ57jJ3RKA5u5c1-KEzNmHktQ_gjRlPpe-BR4xBYsGkQ0CckJ3Dg2s1wJ919833URe91J2YNyCv1iU6zOQMj1dKWnMs9ldMeysc5TjqqfZ5m8VOWcT85h-Ded4X-LF3BQ8-2rmuEl9Ku399UV6tmKXzcc-gSpZX58
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXNrwnSt6L2Y10firikpdW2KWsq29NY-gED2Yar-O97rZv6om8hgcvl4HcfSe4O4KYvzIFZaIacGsKQtVmhysLIdNlIVQyJ0EMX9W_CIOy7ifY01scNmG9zYeo6oR91cUREVIp4L2t9vfq5xKL138r1rZjj1PLB4RaVNtGxUjVOv5Po0LIjRhmRCLFiTwpHlopuCWpijoHSDnrYRgUG-2VYJaWsflsU5wB2IyS2KA-hsX5tQ4tsG6-1YS_YvHfjcAO99RHokWuHE596jp-wEQts7k58OU6GMfd4gvqnF42Y74WPgUftHmFBxJKQHsO1Y3Piyrj_9Pus09jbcsrv1RNoLpaL_BR6hZnmZqqIQsFwLOubIhVo-kWWKTNdKcSgA92_6XT_W7yClssDf4oMPp_BfiXDr8qG59As397zC7S5pbispfUJw5eBbw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHENYLDIFLUOROMETHYL-SUBSTITUTED+PROLINAMIDE+COMPOUND&rft.inventor=TSUCHIYA+Kazuyuki&rft.inventor=IMADA+Sunao&rft.inventor=YAMAMOTO+Eriko&rft.inventor=MATSUMOTO+Shunichiro&rft.inventor=NAKAJIMA+Yutaka&rft.inventor=HARAYAMA+Yu&rft.date=2021-11-30&rft.externalDBID=T1&rft.externalDocID=SI3575284TT1